Synthesis and characterization of a biospecific adsorbent containing bovine serum albumin as a ligand and its use for bilirubin retention

Bilirubin Removal from Albumin - Containing Solution by Adsorption on Polymer Resin

Adsorption equilibrium of bilirubin onto polymeric resins is studied. Solutions containing albumin are used in order to simulate the behavior of systems for removal of albumin-bound substances from blood, serum or dialysis fluids. The effect of albumin pre-loading on the resin is also analysed. Results are explained by a chemically based model that accounts for binding reaction between albumin and bilirubin in the liquid phase.

Thermodynamic equilibria and physical models are essential tools for designing adsorption columns aimed at detoxification treatments.

Bilirubin removal performance of immobilized albumin in a magnetically stabilized fluidized bed

Human serum albumin (HSA)-immobilised magnetic poly(2-hydroxyethyl methacrylate) (mPHEMA) particles were investigated as an adsorbent for selective bilirubin removal from human plasma in a magnetically stabilized fluidized bed system. mPHEMA particles were prepared by suspension polymerization in the presence of Fe3O4 particles. mPHEMA particles were characterized by scanning electron microscopy (SEM), surface area and pore size measurements. The mPHEMA beads have a spherical shape and porous structure. The specific surface area of the mPHEMA particles was found to be 50 m2/g with a size range of 80-120 microm in diameter and the swelling ratio was 45%. Then, HSA was covalently coupled to the cyanogen bromide (CNBr)-activated mPHEMA particles. The amount of coupled HSA was arranged by changing the activation degree of particles (i.e., CNBr concentration). In vitro bilirubin removal was investigated from hyperbilirubinemic human plasma on the mPHEMA particles containing different amounts of immobilised HSA (between 11 and 100 mg/g). The non-specific bilirubin adsorption on the bare mPHEMA particles was 0.47 mg/g. Higher bilirubin adsorption capacities, up to 88.3 mg/g, were obtained with the HSA-immobilised magnetic particles. Bilirubin capacity decreased significantly from 75.0 mg/g to 40.0 mg/g polymer with the increase of the flow-velocity from 0.5 ml/min to 4.0 ml/min. Bilirubin adsorption increased with increasing temperature. Adsorption behavior of bilirubin could be modelled using the Langmuir isotherm.

Bilirubin removal from human plasma by Cibacron Blue F3GA using immobilized microporous affinity membranous capillary method

A novel affinity sorbent system for direct bilirubin removal from human plasma was developed. These new adsorbents comprise Cibacron Blue F3GA as the specific ligand, and microporous membranous poly(tetrafluoroethylene) capillary (modified by coating with a hydrophilic layer of poly(vinyl alcohol) after activation) as the carrier matrix. The affinity adsorbents carrying 126.5 micromol Cibacron Blue F3GA/g polymer was then used to remove bilirubin in a flow-injection system. Non-specific adsorption on the poly(vinyl alcohol) coated capillary remains low, and higher affinity adsorption capacity, of up to 76.2 mg/g polymer was obtained after dye immobilization. The bilirubin adsorption capacity of the affinity capillary decreased with increase in the recirculation rate of plasma. The adsorption capacity increased with increase the temperature while decreased with increase the ionic strength. The maximum adsorption was only observed in neutral solution (pH 6-7). The adsorption isotherm fitted the Langmuir model well. These new adsorbents have higher velocity of mass transfer, better adsorption capacity, less fouling, longer service life and good reusability. The results of blood tests suggested the dye affinity capillary has good blood compatibility.

Adsorptive membranes for bilirubin removal

In this study, we employed ethylene vinyl alcohol (EVAL) adsorptive membranes with bovine serum albumin (BSA) as bioligand for affinity supports for bilirubin (BR) retention. Microfiltration membranes were prepared from ternary or quaternary water/(1-octanol)/DMSO/EVAL systems. To obtain active binding sites for BSA, the EVAL membranes were either chemically functionalized in aqueous and organic medium and by plasma dischargement or physically activated by entrapping of active particles. Static BR removal was determined for all EVAL-BSA membranes. BR retentions relevant for human plasma were gained for the mixed adsorber membranes and additionally investigated in the dynamic mode.